返回 Agenda
Effective Life Cycle Management
Session Chair(s)
Keith Ruark, MBA
Executive Director, Strategy Consulting
INC Research, United States
During development of a novel pharmaceutical candidate, the focus is often on near term and immediate success as costs and attrition need to balance across a portfolio of candidates. However, subsequent to regulatory approval, commercial asset teams are obliged to address several important life cycle expectations. How do organizations manage this space and allocate resources to support? What work/planning can or should be completed pre-approval that would set the program up for success? This forum will give an overview of typical life cycle management activities and walk through some case studies that highlight different approaches (e.g., serial planning, parallel planning).
Learning Objective : Discuss activities and resources needed to effectively manage product life cycle.
Speaker(s)
The State of Life Cycle Management Planning Today: Observations and Lessons Learned
Keith Ruark, MBA
INC Research, United States
Executive Director, Strategy Consulting
From Lab to Launch: Optimizing Intellectual Property Rights in Life Cycle Management Strategy
Marie Manley
Sidley Austin LLP, United Kingdom
Partner, Head of EU and UK Life Sciences (UK)
US Legal Framework and Core Regulatory Intellectual Property Rights
Kellie B. Combs, JD
Ropes & Gray LLP, United States
Partner